We addressed these questions by comparing tumor progression and spinal cord metastasis in a sporadic mouse model of SHH-MB in which rare GCPs are induced to express an oncogenic form of SMO, SmoM2, at postnatal day 0 (P0) and have deletion of one or both copies of Pten. The gene discussed is SMO; the disease is neoplasm.